Transfer of immune complexes from erythrocyte CR1 to mouse macrophages

Journal of Immunology

Volumn 164, Issue 4, 2000, Pages 1977-1985

  Reinagel, Michele L ^a   Taylor, Ronald P ^a  

^a UNIVERSITY OF VIRGINIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BISPECIFIC ANTIBODY; COMPLEMENT COMPONENT C3B RECEPTOR; FICOLL; IMMUNOGLOBULIN F(AB) FRAGMENT; IMMUNOGLOBULIN FC FRAGMENT; MONOCLONAL ANTIBODY;

ANIMAL CELL; ANTIGEN ANTIBODY COMPLEX; ARTICLE; BACTERIOPHAGE PHI X 174; CENTRIFUGATION; CONTROLLED STUDY; ERYTHROCYTE; FLOW CYTOMETRY; HUMAN; HUMAN CELL; IMMUNE ADHERENCE; INTERNALIZATION; MACROPHAGE; MOUSE; NONHUMAN; PHAGOCYTOSIS; PRIORITY JOURNAL; RADIOIMMUNOASSAY;

EID: 0034651937     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: 10.4049/jimmunol.164.4.1977     Document Type: Article

References (47)

1. Nelson R. A. 1953. The immune adherence phenomenon: an immunologically specific reaction between micro-organisms and erythrocytes leading to enhanced phagocytosis. Science 118:733.
2. Schifferli, J. A., and R. P. Taylor. 1989. Physiological and pathological aspects of circulating immune complexes. Kidney Int. 35:993.
3. Cornacoff, J. B., L. A. Hebert, W. L. Smead, M. E. VanAman, D. J. Birmingham, and F. J. Waxman. 1983. Primate erythrocyte-immune complex-clearing mechanism. J. Clin. Invest. 71:236.
4. Fearon, D. T. 1980. Identification of the membrane glycoprotein that is the C3b receptor of the human erythrocyte, polymorphonuclear leukocyte, B lymphocyte, and monocyte. J. Exp. Med. 152:20.
5. Davies, K. A., V. Hird, S. Stewart, G. B. Sivolapenko, P. Jose, A. A. Epenetos, and M. J. Walport. 1990. A study of in vivo immune complex formation and clearance in man. J. Immunol. 144:4613.
6. Davies, K. A., A. M. Peters, H. L. Beynon, and M. J. Walport. 1992. Immune complex processing in patients with systemic lupus erythematosus. In vivo imaging and clearance studies. J. Clin. Invest. 90:2075.
7. Bogers, W. M., R. K. Stad, L. A. Van Es, and M. R. Daha. 1992. Both Kupffer cells and liver endothelial cells play an important role in the clearance of IgA and IgG immune complexes. Res. Immunol. 143:219.
8. Nishi, T., A. K. Bhan, A. B. Collins, and R. T. McCluskey. 1981. Effect of circulating immune complexes on Fc and C3 receptors of Kupffer cells in vivo. Lab. Invest. 44:442.
9. Edberg, J. C., G. A. Kujala, and R. P. Taylor. 1987. Rapid immune adherence reactivity of nascent, soluble antibody/DNA immune complexes in the circulation. J. Immunol. 139:1240.
10. Cosio, F. G., X. P. Shen, D. J. Birmingham, M. Van Aman, and L. A. Hebert. 1990. Evaluation of the mechanisms responsible for the reduction in erythrocyte complement receptors when immune complexes form in vivo in primates. J. Immunol. 145:4198.
11. Madi, N., J. P. Paccaud, G. Steiger, and J. A. Schifferli. 1991. Immune complex binding efficiency of erythrocyte complement receptor 1 (CR1). Clin. Exp. Immunol. 84:9.
12. Taylor, R. P., W. M. Sutherland, C. J. Reist, D. J. Webb, E. L. Wright, and R. H. Labuguen. 1991. Use of heteropolymeric monoclonal antibodies to attach antigens to the C3b receptor of human erythrocytes: a potential therapeutic treatment. Proc. Natl. Acad. Sci. USA 88:3305.
13. Kuhn, S. E., A. Nardin, P. E. Klebba, and R. P. Taylor. 1998. Escherichia coli bound to the primate erythrocyte complement receptor via bispecific monoclonal antibodies are transferred to and phagocytosed by human monocytes in an in vitro model. J. Immunol. 160:5088.
14. Nardin, A., W. M. Sutherland, M. Hevey, A. Schmaljohn, and R. P. Taylor. 1998. Quantitative studies of heteropolymer-mediated binding of inactivated Marburg virus to the complement receptor on primate erythrocytes. J. Immunol. Methods 211:21.
15. Taylor, R. P., E. N. Martin, M. L. Reinagel. A. Nardin, M. Craig, Q. Choice, R. Schlimgen, S. Greenbaum, N. L. Incardona, and H. D. Ochs. 1997. Bispecific monoclonal antibody complexes facilitate erythrocyte binding and liver clearance of a prototype particulate pathogen in a monkey model. J. Immunol. 159:4035.
16. Taylor, R. P., W. M. Sutherland, E. N. Martin, P. J. Ferguson, M. L. Reinagel, E. Gilbert, K. Lopez, N. L. Incardona, and H. D. Ochs. 1997. Bispecific monoclonal antibody complexes bound to primate erythrocyte complement receptor 1 facilitate virus clearance in a monkey model. J. Immunol. 158:842.
17. Emlen, W., V. Carl, and G. Burdick. 1992. Mechanism of transfer of immune complexes from red blood cell CR1 to monocytes. Clin. Exp. Immunol. 89:8.
18. Sundstrom, C., and K. Nilsson. 1976. Establishment and characterization of a human histiocytic lymphoma cell line (U-937). Int. J. Cancer 17:565.
19. Ferguson, P. J., C. J. Reist, E. N. Martin, C. Johnson, K. L. Greene, S. Kuhn, J. Niebur, W. Emlen, and R. P. Taylor. 1995. Antigen-based heteropolymers: a potential therapy for binding and clearing autoantibodies via erythrocyte CR1. Arthritis Rheum. 38:190.
20. Tausk, F. A., A. McCutchan, P. Spechko, R. D. Schreiber, and I. Gigli. 1986. Altered erythrocyte C3b receptor expression, immune complexes, and complement activation in homosexual men in varying risk groups for acquired immune deficiency syndrome. J. Clin. Invest. 78:977.
21. O'Shea, J. J., E. J. Brown, B. E. Seligmann, J. A. Metcalf, M. M. Frank, and J. I. Gallin. 1985. Evidence for distinct intracellular pools of receptors for C3b and C3bi in human neutrophils. J. Immunol. 134:2580.
22. Edberg, J. C., E. Wright, and R. P. Taylor. 1987. Quantitative analyses of the binding of soluble complement-fixing antibody/dsDNA immune complexes to CR1 on human red blood cells. J. Immunol. 139:3739.
23. Segal, D. M., and B. Bast. 1995. Production of bispecific antibodies. In Current Protocols in Immunology. J. E. Coligan, A. M. Kruisbeek, D. H. Margulies, E. M. Shevach, and W. Strober, eds. Wiley, New York, p. 2.13.1.
24. Unkeless, J. C. 1979. Characterization of a monoclonal antibody directed against mouse macrophage and lymphocyte Fc receptors. J. Exp. Med. 150:580.
25. Fraker, P. J., and J. C. Speck, Jr. 1978. Protein and cell membrane iodinations with a sparingly soluble chloroamide, 1,3,4,6-tetrachloro-3a,6a-diphenylglycoluril. Biochem. Biophys. Res. Commun. 80:849.
26. Bayer, E. A., and M. Wilchek. 1990. Protein biotinylation. Methods Enzymol. 184:138.
27. Harlow, E., and D. Lane. 1988. Antibodies: a Laboratory Manual. Cold Spring Harbor Laboratory, Cold Spring Harbor, p. 354.
28. Reist, C. J., M. J. Combs, B. Y. Croft, and R. P. Taylor. 1993. Antigens prebound to the primate erythrocyte complement receptor via cross-linked bispecific monoclonal antibody heteropolymers are rapidly cleared from the circulation. Eur. J. Immunol. 23:3021.
29. Edberg, J. C., L. Tosic, E. L. Wright, W. M. Sutherland, and R. P. Taylor. 1988. Quantitative analyses of the relationship between C3 consumption, C3b capture, and immune adherence of complement-fixing antibody/DNA immune complexes. J. Immunol. 141:4258.
30. Reinagel, M. L., M. Gezen, P. J. Ferguson, S. Kuhn, E. N. Martin, and R. P. Taylor. 1997. The primate erythrocyte complement receptor (CR1) as a privileged site: binding of immunoglobulin G to erythrocyte CR1 does not target erythrocytes for phagocytosis. Blood 89:1068.
31. Brenner, S. L., and E. D. Korn. 1979. Substoichiometric concentrations of cytochalasin D inhibit actin polymerization: additional evidence for an F-actin treadmill. J. Biol. Chem. 254:9982.
32. Flanagan, M. D., and S. Lin. 1980. Cytochalasins block actin filament elongation by binding to high affinity sites associated with F-actin. J. Biol. Chem. 255:835.
33. Reist, C. J., H. Y. Liang, D. Denny, E. N. Martin, W. M. Scheld, and R. P. Taylor. 1994. Cross-linked bispecific monoclonal antibody heteropolymers facilitate the clearance of human IgM from the circulation of squirrel monkeys. Eur. J. Immunol. 24:2018.
34. Taylor, R. P., P. J. Ferguson, E. N. Martin, J. Cooke, K. L. Greene, K. Grinspun, M. Guttman, and S. Kuhn. 1997. Immune complexes bound to the primate erythrocyte complement receptor (CR1) via anti-CR1 mAbs are cleared simultaneously with loss of CR1 in a concerted reaction in a rhesus monkey model. Clin. Immunol. Immunopathol. 82:49.
35. Kurlander, R. J., D. M. Ellison, and J. Hall. 1984. The blockade of Fc receptor-mediated clearance of immune complexes in vivo by a monoclonal antibody (2. 4G2) directed against Fc receptors on murine leukocytes. J. Immunol. 133:855.
36. Waxman, F. J., L. A. Hebert, J. B. Cornacoff, M. E. VanAman, W. L. Smead. E. H. Kraut, D. J. Birmingham, and J. M. Taguiam. 1984. Complement depletion accelerates the clearance of immune complexes from the circulation of primates. J. Clin. Invest. 74:1329.
37. Brown E. J. 1998. Cooperation between IgG Fc receptors and complement receptors in host defence. In The Immunoglobulin Receptors and Their Physiological and Pathological Roles in Immunity. J. G. van de Winkel and P. M. Hogarth, eds. Kluwer, Boston, p. 141.
38. Weigle W. O. 1958. Elimination of antigen-antibody complexes from the sera of rabbits. J. Immunol. 81:204.
39. Mannik, M., M. P. Arend, A. P. Hall, and B. C. Gilliland. 1971. Studies on antigen-antibody complexes. I. Elimination of soluble complexes from rabbit circulation. J. Exp. Med. 133:713.
40. Haakenstad, A. O., and M. Mannik. 1976. The disappearance kinetics of soluble immune complexes prepared with reduced and alkylated antibodies and with intact antibodies in mice. Lab. Invest. 35:283.
41. Finbloom, D. S., and P. H. Plotz. 1979. Studies of reticuloendothelial function in the mouse with model immune complexes. I. Serum clearance and tissue uptake in normal C3H mice. J. Immunol. 123:1594.
42. Bazil, V., and J. L. Strominger 1994. Metalloprotease and serine protease are involved in cleavage of CD43, CD44, and CD16 from stimulated human granulocytes: induction of cleavage of L-selectin via CD16. J. Immunol. 152:1314.
43. Bauvois, B., J. Sanceau, and J. Wietzerbin. 1992. Human U937 cell surface peptidase activities: characterization and degradative effect on tumor necrosis factor-α. Eur. J. Immunol. 22:923.
44. Kahn, J., R. H. Ingraham, F. Shirley, G. I. Migaki, and T. K. Kishimoto. 1994. Membrane proximal cleavage of L-selectin: identification of the cleavage site and a 6-kD transmembrane peptide fragment of L-selectin. J. Cell Biol. 125:461.
45. Chen, A., P. Engel, and T. F. Tedder. 1995. Structural requirements regulate endoproteolytic release of the L-selectin (CD62L) adhesion receptor from the cell surface of leukocytes. J. Exp. Med. 182:519.
46. Preece, G., G. Murphy, and A. Ager. 1996. Metalloproteinase-mediated regulation of L-selectin levels on leukocytes. J. Biol. Chem. 271:11634.
47. Fremeaux-Bacchi, V., I. Bernard, F. Maillet, J. C. Mani, M. Fontaine, J. Y. Bonnefoy, M. D. Kazatchkine, and E. Fischer. 1996. Human lymphocytes shed a soluble form of CD21 (the C3dg/Epstein-Barr virus receptor, CR2) that binds iC3b and CD23. Eur. J. Immunol. 26:1497.